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Abstract 
Study question: Is vascular smooth muscle cell (VSMC) dedifferentiation a feature of 
uterine spiral artery (SpA) remodelling in early human pregnancy? 
Summary answer: Remodelling of human uterine SpAs is associated with 
dedifferentiation of VSMCs and can be induced in vitro by uterine natural killer (uNK) 25 
cells and extravillous trophoblast cells (EVTs). 
What is known already: Uterine SpAs undergo profound morphological changes in 
normal pregnancy with replacement of the musculoelastic arterial wall structure by 
fibrinoid containing EVTs.  The fate of VSMCs in SpA remodelling is unknown; in 
guinea pig uterine artery VSMCs dedifferentiate, remain in the vessel wall and 30 
differentiate after parturition to restore the arterial wall.  There is increasing evidence 
that uNK cells play a role in SpA remodelling.  We hypothesised that SpA remodelling 
in human pregnancy is associated with VSMC dedifferentiation, initiated by uNK cell 
derived growth factors.  
Study design, size, duration: Formalin fixed, paraffin embedded placental bed 35 
biopsies were immunostained for angiogenic growth factor (AGF) receptors and 
markers of VSMC differentiation.  An in vitro model of SpA remodelling using chorionic 
plate arteries (CPAs) was used to test the effect of different cell types and AGFs on 
VSMC differentiation. 
Participants/materials, setting, methods: Placental bed biopsies were 40 
immunostained for vascular endothelial growth factor receptors 1-3 (VEGF-R1, VEGF-
R2, VEGF-R3), transforming growth factor beta 1 receptors I and II (TGF-βRI, TGF-
βRII), interferon gamma receptors 1 and 2 (IFN-γR1, IFN-γR2), Tie2, α-smooth muscle 
actin (α-SMA), H-caldesmon (H-Cal), myosin heavy chain (MyHC), osteopontin and 
smoothelin.  Staining intensity was assessed using a modified quickscore.  Expression 45 
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by VSMCs of the AGF receptors was confirmed by laser capture microdissection and 
real time RT-PCR of non-remodelled SpAs, after laser removal of the endothelium.  As 
an in vitro model, VSMC differentiation was assessed in CPAs by 
immunohistochemistry after culture in uNK cell conditioned medium (CM), EVT-CM, 
uNK cell/EVT co-culture CM, Ang-1, Ang-2, IFN-γ, VEGF-A and VEGF-C, and after 50 
blocking of both Ang-1 and Ang-2 in uNK-CM. 
Main results and the role of chance:  SpA VSMC expression of Tie-2 (P=0.0007), 
VEGF-R2 (P=0.005) and osteopontin (P=0.0001) increased in partially remodelled 
SpAs compared with non-remodelled SpAs, while expression of contractile VSMC 
markers was reduced (α-SMA P<0.0001, H-Cal P=0.03, MyHC P=0.03, smoothelin 55 
P=0.0001).  In the in vitro CPA model, supernatants from purified uNK cell (H-Cal 
P<0.0001, MyHC P=0.03, α-SMA P=0.02, osteopontin P=0.03), EVT (H-Cal P=0.0006, 
MyHC P=0.02, osteopontin P=0.01) and uNK cell/EVT co-cultures (H-Cal P=0.001, 
MyHC P=0.05, osteopontin P=0.02) at 12-14 weeks, but not 8-10 weeks, gestational 
age induced reduced expression of contractile VSMC markers, and increased 60 
osteopontin expression.  Addition of exogenous (10ng/ml) Ang-1 (P=0.006) or Ang-2 
(P=0.009) also reduced H-Cal expression in the CPA model.  Inhibition of Ang-1 
(P=0.0004) or Ang-2 (P=0.004) in uNK cell supernatants blocked the ability of uNK 
cell supernatants to reduce H-Cal expression.  
Limitations, reasons for caution: This is an in vitro study and the role of uNK cells, 65 
Ang-1 and Ang-2 in SpA remodelling in vivo has not yet been shown. 
Wider implications of the findings: VSMC dedifferentiation is a feature of early SpA 
remodelling and uNK cells and EVT play key roles in this process by secretion of Ang-
1 and Ang-2.  This is one of the first studies to suggest a direct role for Ang-1 and Ang-
2 in VSMC biology. 70 
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Introduction 80 
Uterine spiral arteries (SpA) in decidualised endometrium and inner myometrium 
undergo profound morphological changes in successful human pregnancy.  Deficient 
SpA remodelling occurs in various pregnancy complications, including pre-eclampsia, 
fetal growth restriction, preterm labour and late miscarriage (Brosens et al., 2011).  As 
well as direct fetal and maternal morbidity and mortality, these conditions may also 85 
impact on health in later life for mothers and surviving babies (Barker, 2007; Brown et 
al., 2013; Wu et al., 2017).  
 
SpA remodelling is characterised by replacement of medial vascular smooth muscle 
cells (VSMCs), extracellular matrix and elastic lamina by amorphous fibrinoid material 90 
containing intramural extravillous trophoblast cells (EVTs) (Pijnenborg et al., 2006; 
Smith et al., 2016).  EVTs are required for complete SpA remodelling but there is 
increasing evidence for a maternal-mediated ‘priming’ phase preceding EVT invasion: 
‘decidua-associated’ or ‘trophoblast-independent’ remodelling (Pijnenborg et al., 
2006).  SpAs in early pregnancy show dilatation, endothelial cell vacuolisation and 95 
basophilia, and VSMC hyperplasia, vacuolisation, separation and disorganisation in 
the absence of EVTs (Craven et al., 1998; Kam et al., 1999; Pijnenborg et al., 2006).   
 
CD56+ uterine natural killer (uNK) cells account for up to 70% of leucocytes in decidual 
stroma in the first trimester (Bulmer et al., 1991); their accumulation around SpAs 100 
suggests a role in remodelling (Smith et al., 2009; Lash et al., 2016).  Furthermore, 
uNK cells from early pregnancy decidua produce a range of angiogenic growth factors 
(AGFs) including angiopoietin-1 (Ang-1), Ang-2, transforming growth factor beta 1 
(TGF-β1), vascular endothelial growth factor-C (VEGF-C), interleukin 8 (IL-8) and 
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interferon gamma (IFN-γ) (Hanna et al., 2006; Lash et al., 2006), all of which can cause 105 
morphological changes to pre-existing vascular networks (Distler et al., 2003; Ferrara, 
2004).  Using an in vitro model of SpA remodelling we have demonstrated that uNK 
cells from early human pregnancy can induce morphological changes in VSMCs 
(Robson et al., 2012). 
 110 
The cellular mechanisms that underlie medial VSMC loss in SpAs in human pregnancy 
are not fully understood.  Apoptosis has been suggested (Smith et al., 2009), but 
appears to be a rare event within the SpA artery wall itself (Bulmer et al., 2012).  
However, VSMCs migrate away from the SpA wall into decidual stroma during 
remodelling where they then appear to undergo apoptosis (Bulmer et al., 2012; Lash 115 
et al., 2016).  In guinea pig, uterine VSMCs exhibit polygonal morphology and loss of 
desmin and α-smooth muscle actin (α-SMA) in pregnancy, with restoration three days 
post-parturition, suggesting that uterine VSMCs dedifferentiate during artery 
remodelling (Nanaev et al., 1995, 2000). 
 120 
VSMCs can switch from contractile to synthetic phenotype according to local 
environmental cues (McDonald and Owens, 2007).  Contractile VSMCs are elongated, 
spindle shaped cells characterised by high expression of contractile marker proteins 
such as α-SMA, H-caldesmon (H-cal) and myosin heavy chain (MyHC), whereas 
synthetic VSMCs have low contractile marker expression, less elongated rhomboid 125 
morphology and are more motile (Rensen et al., 2007).  Modifiers of VSMC phenotype 
in vitro include biochemical factors such as platelet derived growth factor (PDGF) and 
TGF-β1, extracellular matrix components and physical factors such as tensile stress 
(Rensen et al., 2007; Rzucidlo et al., 2007). 
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 130 
In view of reports of uterine artery VSMC dedifferentiation in guinea pig, VSMC motility 
in humans and high AGF secretion by uNK cells, we hypothesised that VSMCs 
undergo dedifferentiation during SpA remodelling, mediated by paracrine signalling 
through uNK cell derived factors.  To test this hypothesis, we examined expression of 
VSMC differentiation markers in both non-remodelled SpAs and SpAs in early stages 135 
of remodelling in the absence of EVT and used an in vitro model to determine which 
uNK cell derived AGFs may initiate VSMC dedifferentiation.  
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Materials and Methods 
Samples 140 
Placental bed biopsies for immunohistochemical studies were obtained as previously 
described (Robson et al., 2002) after elective surgical termination of apparently 
normal pregnancy at 8-14 weeks gestational age (n=15).  Placenta and decidua for 
uNK cell and EVT cultures were obtained at 8-10 and 12-14 weeks gestational age 
from women undergoing elective pregnancy termination (n=10 each group).  145 
Chorionic plate artery (CPA) segments were obtained from normal term placenta 
delivered by elective caesarean section (n=13).  The study had local ethical approval 
(National Research Ethics Service Committee Sunderland, ref 07/H0904/74; 
Newcastle & North Tyneside 1, ref 10/H0906/71) and written informed consent was 
obtained from all subjects. 150 
 
Formalin fixed, paraffin embedded placental bed biopsies were sectioned at 3µm and 
immunostained as described previously to confirm the presence of decidua, 
myometrium, EVT and SpAs (Robson et al., 2002).  Samples selected contained non-
remodelled SpAs or SpAs with features of early partial remodelling (dilatation, VSMC 155 
separation and morphological change) (Lash et al., 2016). 
 
Immunohistochemistry 
Immunohistochemistry was performed on paraffin sections as described previously 
(Schiessl et al., 2009) using an avidin-biotin peroxidise method (Vectastain Elite, 160 
Vector Laboratories, Peterborough, UK).  Primary antibody specificities, dilutions, pre-
treatments and incubation conditions are shown in Table I.  Sections were lightly 
counterstained with Mayer’s haematoxylin (BDH, Poole, UK) and mounted with DPX 
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synthetic resin (Raymond Lamb, London, UK).  Appropriate positive controls were 
performed in each staining run and a negative control was performed for each sample 165 
by replacing the antibody with non-immune serum.  For any individual antibody, all the 
samples to be analysed were stained in a single staining run with the appropriate 
positive control to avoid day to day variation.   
Laser capture microdissection and real time RT-PCR 170 
Laser capture microdissection and RT-PCR was used to confirm the presence or 
absence of mRNA corresponding to AGF receptor expression in VSMCs identified by 
immunohistochemistry. 
10µm cryosections of placental bed biopsies (n=6) were cut onto 2µm PEN-Membrane 175 
slides (Leica Microsystems, Wetzlar, Germany) and stained with cresyl violet LCM 
staining kit (Ambion, TX, USA) to allow SpA identification.  Initially the lumen and 
endothelial cells were laser microdissected using a Leica AS LMD microscope (Leica 
Microsystems) and removed as waste.  The remaining SpA wall containing VSMCs 
was then laser microdissected and used for RT-PCR. 180 
Total RNA was extracted using RNAqueous Micro (Ambion) and reverse transcribed 
to cDNA using Superscript III (InVitrogen, Paisley, UK.  Real time RT-PCR was 
performed using Taqman chemistry, 2μl cDNA per 20μl reaction with Taqman 
Universal PCR MasterMix (Applied Biosystems, CA, USA) and run on an ABI7000 real 185 
time PCR machine (Applied Biosystems).  Probe/primer sets were purchased from 
Assays on Demand (Applied Biosystems) for GAPDH (housekeeping gene), Tie-2, 
TGF-βRI, TGF-βRII, VEGF-R1, VEGF-R2, VEGF-R3, IFN-γR1 and IFN-γR2. Due to 
10 
the very small size of the laser capture dissected samples and the number of genes 
investigated the concentration of cDNA was extremely limited.  PCR reactions were 190 
therefore run for 50 cycles.  All probe/primer sets were validated for use with a 
laboratory standard total RNA extracted from early pregnancy decidua.   
Isolation and culture of CD56+ uNK cells, EVT and uNK cell/EVT co-cultures 
Decidua and placenta were taken from the same patient for isolation of both uNK cells 195 
and EVTs. 
uNK cell-enriched isolates were prepared by enzymatic disaggregation and positive 
immunomagnetic selection (Miltenyi Biotech, Bisley, UK) as described previously 
(Lash et al., 2006).  To prepare uNK cell-conditioned medium (uNK-CM), cells were 200 
cultured at 1x106 cells/ml in RPMI1640 complete medium (RPMI containing 10% (v/v) 
fetal calf serum, 1%5U/ml penicillin, 0.05mg/ml/ streptomycin, 1%1.5µg/ml 
amphotericin; Sigma-Aldrich).  After 24 hours the uNK-CM was removed, centrifuged 
and stored at -80 oC.  Cell purity and viability were tested routinely by immunostaining 
cell smears and trypan blue exclusion, respectively; both were consistently >95%. 205 
EVTs were isolated as previously described (Lash et al., 2010a) and cultured at 1x106 
cells/ml in DMEM:Ham’s F12 (Sigma-Aldrich) complete medium in a 24 well plate 
coated with growth factor reduced Matrigel (BD Biosciences, Oxford, UK).  
Conditioned medium was harvested (EVT-CM) after 24 hours, centrifuged and stored 210 
at -80 oC.  Cell purity and viability were assessed after 24 hours of culture by 
immunostaining cell smears (HLA-G, cytokeratin 7) (Lash et al., 2010a) and trypan 
blue exclusion, respectively; both were consistently >95%. 
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For co-culture of uNK cells and EVTs, 1x106 EVT cells were cultured in DMEM:F12 215 
complete medium in a 24 well plate overnight prior to addition of 1x106 uNK cells (from 
the same patient) in DMEM:Ham’s F12 to a total volume of 1ml (Lash et al., 2011; 
Robson et al., 2012).  After 24 hours co-culture, the conditioned medium (uNK/EVT-
CM) was removed, centrifuged and stored at -80 °C.  Viability of co-cultures was 
assessed after 24 hours of culture and was consistently >95%. 220 
 
Isolation and culture of chorionic plate arteries 
Intact CPA segments (5mm length) (Robson et al., 2012; Pitman et al., 2013; Lash et 
al., 2016) were dissected from normal term placenta and cultured at 37 C in 5% CO2 
in: (A) conditioned medium: 20% (v/v) uNK-CM, EVT-CM or uNK/EVT-CM (8-10 or 12-225 
14 weeks’ gestation; n=6 each gestational age group and CM type); (B) angiogenic 
growth factors: 1ng/ml and 10ng/ml VEGF-A, VEGF-C, Ang-1, Ang-2, IFN-γ or TGF-
β1 (all from R&D Systems, Abingdon, UK; n=10 each growth factor); (C) conditioned 
medium and anti-angiogenic growth factor neutralising antibody: 20% (v/v) uNK-CM, 
EVT-CM or uNK/EVT-CM (8-10 or 12-14 weeks gestation; n=5 each experiment) with 230 
or without anti-Ang-1 (1μg/ml; Millipore, Watford, UK), anti-Ang-2 (10µg/ml; Amgen, 
Seattle, Washington); or (D) medium only controls: RPMI1640 complete medium 
control and a citric acid control for TGF-β1, which is reconstituted in citric acid.  The 
medium was replaced every 48 hours.  CPAs were harvested after 120 hours, fixed in 
formalin for 24 hours and embedded in paraffin wax.  Three µm serial sections were 235 
immunostained for: H-cal, MyHC and α-SMA to determine the differentiation state of 
CPA VSMCs after culture; cleaved caspase-3 to verify cell viability; Ki67 to examine 
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cell proliferation in order to ensure that any differences detected were not due to 
altered cell proliferation; and CD31 to confirm endothelial integrity. 
 240 
Analysis of immunostaining 
For assessment of VSMC differentiation marker expression, digital images of 
immunostained decidual SpAs and CPAs were captured using a Nikon Eclipse 80i 
microscope coupled with a DS-Fi1 camera and NIS elements D software.  In Adobe 
Photoshop (Adobe Systems Inc., San Jose, CA, USA) individual SpAs were selected 245 
using the magnetic lasso tool and copied to a new layer within the image, where a 
positively stained area was identified by eye and selected using the magic wand tool.  
Other immunopositive areas were then selected using the ‘similar’ command, with the 
threshold level set such that all positive areas but no negative areas were selected.  
The immunopositive areas were then copied into a new layer.  The pixel number in 250 
each layer was noted and the number of positive pixels in immunostained sections 
was expressed as a percentage of the total pixel number in the vessel wall for each 
SpA or CPA segment (Pitman et al., 2013; Lash et al., 2016). 
 
VSMC immunostaining for AGF receptors was assessed in non-remodelled (n=33 255 
SpAs) and partially remodelled (n=33 SpAs) SpAs using a modified quickscore taking 
into account both percentage of cells stained and intensity of staining (Schiessl et al., 
2009).  The degree of remodelling was determined in serial sections immunostained 
for MyHC and cytokeratin 7 with non-remodelled SpA showing no signs of remodelling 
and partially remodelled SpA displaying separated and rounded VSMCs but no 260 
associated EVT. 
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Statistical Analysis 
Data are presented as mean ± standard error of the mean (SEM).  Statistical analyses 
were performed using the StatView statistical software package (Abacus Concepts, 265 
Berkley, CA, USA).  Statistical significance was determined using a one-way ANOVA, 
followed by Fisher’s post hoc analysis unless otherwise stated.  Differences were 
considered statistically significant at P<0.05. 
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Results 
Uterine spiral arteries express receptors for angiogenic growth factors  270 
We investigated AGF receptor expression by VSMCs in non- and partially remodelled 
SpAs (Figure 1A).  There was moderate to strong expression of VEGF-R1 and VEGF-
R2 in SpA VSMCs, with weaker VEGF-R3 expression.  TGF-βRI, TGF-βRII and IFN-
γR1 were moderately expressed, although IFN-γR2 immunoreactivity was weaker.  
Tie-2, the receptor for Ang-1 and Ang-2 was weakly to moderately expressed.  Scores 275 
for most AGF receptors did not differ between non- and partially remodelled SpAs 
(Figure 1B) but immunostaining was increased in partially remodelled compared with 
non-remodelled SpAs for VEGF-R2 (P=0.005) and Tie-2 (P=0.0007) (Figure 1A, 1B). 
 
Expression of mRNA for VEGF-R1, VEGF-R2, VEGF-R3, TGF-βRI, TGF-βRII, IFN-280 
γR1, IFN-γR2 and Tie-2 in VSMCs of SpAs was confirmed with laser capture 
microdissection coupled with real-time RT-PCR in all samples examined (n=6 samples; 
Figure 1C). PCR reactions were run for 50 cycles and for each gene the cycle number 
at threshold was higher than ideal.  However, all reactions demonstrated classical 
amplification curves and reached saturation prior to 50 cycles (GAPDH 31, H-cal 35, 285 
Tie-2 34, IFNγ-R1 40, IFNγ-R2 34, TGF-βRI 34, TGF-βRII 31, VEGF-R1 26, VEGF-
R2 38, VEGF-R3 37). 
 
Vascular smooth muscle cells of partially transformed spiral arteries switch 
from a contractile to a more synthetic phenotype  290 
Markers of contractile (α-SMA, calponin, H-cal, MyHC, smoothelin) and synthetic 
(osteopontin) VSMC phenotype were compared between non- and partially 
remodelled SpAs (n=15 SpAs each group) at 8-14 weeks gestational age (Figure 2A).  
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Partially remodelled SpAs showed endothelial swelling and separation of medial 
VSMCs but no intramural or endovascular EVTs, indicating an early stage of SpA 295 
remodelling prior to invasion of vessel wall and lumen by EVTs  (7); SpAs were 
classified as non- and partially remodelled by two investigators (JNB, AR).   
 
Expression of H-cal (P=0.0003), α-SMA (P<0.0001), MyHC (P=0.001), and smoothelin 
(P=0.0001) was reduced and osteopontin (P=0.008) expression was increased in 300 
partially compared with non-remodelled SpAs.  In order to correct for the possibility 
that the number of VSMCs in SpAs was reduced in partially remodelled SpA, 
immunopositivity for each VSMC marker was also expressed as a percentage of 
calponin immunopositivity (Figure 2B), an early marker of VSMC differentiation whose 
expression remained high and showed minimal changes in expression in partially 305 
remodelled vessels.  When expressed as a percentage of calponin immunoreactivity, 
expression of α-SMA (P<0.0001), H-cal (P=0.03), MyHC (P=0.03) and smoothelin 
(P=0.0001) was reduced and osteopontin (P=0.0001) was increased in partially 
remodelled SpAs compared with non-remodelled SpAs (Figure 2A, 2B).  These results 
suggest that in the early stages of remodelling SpA VSMCs show loss of their 310 
contractile phenotype, adopting a more synthetic or dedifferentiated phenotype.  
 
uNK cell, EVT and uNK cell:EVT conditioned medium stimulates VSMC 
dedifferentiation in chorionic plate arteries in vitro 
We tested the hypothesis that uNK cells initiate VSMC dedifferentiation by 315 
quantification of α-SMA, H-cal, MyHC and osteopontin immunoreactivity in an in vitro 
CPA model (Robson et al., 2012; Pitman et al., 2013; Lash et al., 2016).  Expression 
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by CPA VSMC of receptors for Ang-1, Ang-2, IFN-γ, TGF-β1, VEGF-A and VEGF-C 
was initially confirmed by immunohistochemistry (Figure 3C).   
 320 
All CPAs were immunostained for caspase 3, Ki67 and CD31 after culture.  There was 
no evidence of caspase 3 immunopositivity, confirming viability.  The endothelium was 
intact as demonstrated by immunostaining for CD31; CD31-negative vessels 
(reflecting endothelial loss) were excluded from the study.  There was minimal Ki67 
immunopositivity, confirming that proliferation was not altered after culture. CPAs 325 
cultured with uNK-CM, EVT-CM or uNK/EVT-CM from 8-10 weeks gestational age 
showed no difference in H-cal, MyHC, α-SMA or osteopontin expression (Figure 4A-
4D) compared with medium only controls.  However, reduced H-cal and MyHC 
expression was observed after culture in uNK-CM (H-cal P<0.0001; MyHC P=0.03), 
EVT-CM (H-cal P=0.0006; MyHC P=0.02) or uNK/EVT-CM (H-cal P=0.001; MyHC 330 
P=0.05) from 12-14 weeks gestational age (Figure 4A, 4B).  Osteopontin expression 
was increased after culture in uNK-CM (P=0.03), EVT-CM (P=0.01) and uNK/EVT-CM 
(P=0.02) from 12-14 weeks gestational age (Figure 4D).  α-SMA expression was 
reduced only after culture in uNK-CM (P=0.02) from 12-14 weeks gestational age 
samples (Figure 4C).   335 
 
Ang-1 and Ang-2 reduce H-cal expression in CPA  
To identify whether AGFs produced by uNK cells mediate VSMC dedifferentiation, 
CPAs were cultured with 1ng/ml and 10ng/ml recombinant AGFs and H-cal expression 
assessed.  There was no effect on H-cal expression after incubation of CPAs with both 340 
concentrations of IFN-γ, VEGF-A and VEGF-C (Figure 3A).  1ng/ml Ang-1 and Ang-2 
also had no effect but incubation of CPAs in 10ng/ml recombinant human Ang-1 
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(P=0.006) and Ang-2 (P=0.009) reduced VSMC expression of H-cal (Figure 3A).  TGF-
β1 was excluded from this part of the study since the citric acid used to reconstitute 
TGF-β1 reduced expression of the VSMC marker studied (data not shown).  345 
Neutralisation of uNK cell secreted Ang-1 and Ang-2 activity partially restored 
contractile VSMC marker expression 
Neutralising antibodies to Ang-1 or Ang-2 were added to 12-14 week gestational age 
uNK-CM and CPAs cultured for 120 hours.  Neutralisation of both Ang-1 (P=0.0004) 350 
and Ang-2 (P=0.004) restored H-cal expression (Figure 3B).   
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Discussion 
In the current study we have demonstrated that in early remodelling, in the absence 
of EVT infiltration, SpA VSMCs show loss of contractile phenotype.  Furthermore, 355 
AGFs produced by uNK cells and EVTs can mediate this VSMC de-differentiation in 
an in vitro model (Lash et al., 2006, 2010a).    
 
We have demonstrated expression of protein and mRNA for receptors for Ang-1, Ang-
2, IFN-γ, TGF-β1, VEGF-A and VEGF-C in uterine SpA VSMCs.  Expression of VEGF-360 
R2 and Tie-2 correlate with the high levels of VEGF-C, Ang-1 and Ang-2 secreted by 
uNK cells in early pregnancy and suggest a role in trophoblast-independent SpA 
remodelling.  Interestingly, VEGF-R2 and Tie-2 expression was increased in partially 
remodelled SpAs, at a gestational age when levels of uNK cell secreted AGFs are 
decreasing (Lash et al., 2006).  In partially remodelled SpAs there is separation and 365 
some dedifferentiation of VSMCs, but they are not yet lost.  Increased receptor 
expression may reflect altered VSMC phenotype as they prepare to migrate away from 
the SpA.  Despite high VEGF-R1 expression in SpA VSMCs, uNK secretion of VEGF-
A is low, although EVTs secrete high levels of this AGF (Lash et al., 2010a).  Taken 
together, these data confirm that SpAs express AGF receptors and are a potential 370 
target for uNK cell derived factors.   
 
The main function of VSMCs is to control vessel contraction, thereby regulating blood 
vessel tone and blood pressure.  VSMCs exhibit plasticity and can dedifferentiate in 
response to local environmental signals during vascular development or vascular 375 
injury (Owens, 1995, 2007).  VSMCs acquire specific markers as they differentiate to 
a contractile phenotype, which are lost when they dedifferentiate into a more synthetic 
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phenotype.  Regulation of VSMC differentiation/dedifferentiation is complex and 
involves local cues including mechanical forces, extracellular matrix interactions, local 
cytokines, growth factors and epigenetic control (Owens et al., 2004; Alexander and 380 
Owens, 2012).  α-SMA is the first contractile marker expressed during development, 
at approximately embryonic day 2.5 in chick (Owens, 1995), and is the most abundant 
actin isoform in mature differentiated VSMCs (Fatigati and Murphy, 1984).  H-cal is 
the most abundantly expressed caldesmon isoform in differentiated VSMC and is a 
later marker of VSMC differentiation than α-SMA (Sobue and Sellers, 1991; Stouffer 385 
and Owens, 1994), being expressed at around embryonic day 6 in chick (Owens, 
1995).  MyHC is part of the contractile apparatus in all muscle cells and consists of 
two isoforms SM-1 and SM-2 produced by alternative splicing.  These isoforms are 
late markers of VSMC differentiation, with SM-2 expressed ~10 days postpartum 
(Fatigati and Murphy, 1984; Kuro-o et al., 1989).  Calponin is a regulator of VSMC 390 
contraction and is a relatively early marker of VSMC differentiation expressed from 
day 4 in chick embryo (Owens, 1995).  Smoothelin is a late VSMC differentiation 
marker and mouse knockout studies suggest that it is required for contractile potential 
(van Eys et al., 2007).  Osteopontin is a secreted acidic glycosylated phosphoprotein 
that interacts with integrins and extracellular matrix; expression is increased in 395 
dedifferentiated VSMCs and osteopontin regulates expression of α-SMA and calponin 
(Gao et al., 2012).   
 
We demonstrated reduced immunostaining for α-SMA, H-cal, MyHC and smoothelin 
within the walls of SpAs undergoing early remodelling prior to EVT infiltration.  These 400 
data suggest that in early remodelling SpA VSMCs become less contractile; this 
reduced expression of contractile proteins is similar to that reported in vascular 
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diseases such as atherosclerosis (Ross, 1993) and may account for the dilatation in 
early SpA remodelling (Craven et al., 1998; Pijnenborg et al., 2006).  Osteopontin 
expression, indicating synthetic VSMC phenotype (Weissgerber et al., 2010), was 405 
increased in the same SpAs.  The functional importance of this increased osteopontin 
expression is unknown but osteopontin promotes VSMC migration in vitro (Li et al., 
2007).  We have demonstrated that VSMCs migrate away from the SpA wall during 
early SpA transformation (Bulmer et al., 2012); this may reflect a synthetic phenotype 
capable of migration.  This is the first demonstration of phenotypic changes in SpA 410 
VSMCs in early SpA remodelling in the absence of EVT and supports evidence from 
guinea pig pregnancy of dedifferentiation of uterine artery VSMCs (Nanaev et al., 
1995).  A recent study has reported that predecidual stromal cells express pericyte 
markers, including α-SMA and the contribution of these cells to decidual SpA 
remodelling should also be considered (Munoz-Fernandez et al., 2018). 415 
 
Using a CPA model we assessed the effects of uNK cell, EVT and uNK cell/EVT 
conditioned medium on VSMC dedifferentiation in vitro.  Both uNK cells and EVT 
supernatants reduced VSMC expression of H-cal, MyHC and α-SMA and increased 
osteopontin expression.  Although MyHC is the latest VSMC differentiation marker of 420 
the three examined, H-cal showed most loss in expression.  A possible explanation is 
that the MyHC antibody recognises both SM-1 and SM-2; these isoforms may show 
differential regulation, although this cannot be concluded from our data.  In a study 
using an aorta VSMC cell line, α-SMA and calponin expression were decreased after 
culture in EVT-CM (Wallace et al., 2013).  The authors hypothesised that this may be 425 
attributed to CXCL10, although this chemokine stimulated VSMC motility but had no 
effect on VSMC contractile protein expression (Wallace et al., 2013).   
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Interestingly we only observed contractile muscle protein loss after culture with 
supernatants from 12-14 weeks’ but not 8-10 weeks’ gestation.  Both groups secrete 430 
high levels of AGFs, although levels of Ang-2 and VEGF-C were reduced at 12-14 
weeks’ compared with 8-10 weeks’ gestation (Lash et al., 2006).  A possible 
explanation is that the SpA VSMCs must first undergo separation of the previously 
intact layers; this process is initiated by 8-10 weeks’ gestation uNK cell culture 
supernatants (Robson et al., 2012).  We also observed that EVT-CM and uNK 435 
cell/EVT-CM reduced expression of H-cal and MyHC, but not α-SMA, although for H-
cal the effect of EVT-CM and uNK cell/EVT-CM was not as potent as that of uNK-CM.  
These data suggest that close proximity of uNK cells and EVT cells may lead to mutual 
suppression of function; previous data from our laboratory demonstrated reduced 
secretion of several cytokines and AGFs in uNK cell/EVT co-cultures compared with 440 
cultures of individual cell types (Lash et al., 2011).  The gestational age differences in 
the effect of the uNK cell and EVT supernatants suggests that this is not a non-specific 
effect.  Furthermore, isolated decidual macrophages did not affect VSMC 
dedifferentiation in the CPA model, despite their production of high levels of AGFs 
(Lash et al., 2016). 445 
 
Ang-1 and Ang-2 reduced expression of H-cal in the CPA model and addition of Ang-
1 and Ang-2 neutralising antibody abrogated the effect of uNK-CM on H-cal expression.  
This is one of the first descriptions of Ang-1 and Ang-2 playing similar roles and having 
biological effects on VSMCs.  The mechanism of action warrants further study. 450 
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We propose a working model of the cells and molecular mediators involved in SpA 
remodelling.  In early gestation SpAs are surrounded by uNK cells and macrophages 
which facilitate breakdown of extracellular matrix in the vessel wall via matrix 
metalloproteinase secretion (Hazan et al., 2010; Robson et al., 2012; Lash et al., 2016).  455 
Matrix metalloproteinases have also been localised within the SpA wall itself (Hazan 
et al 2010).  uNK cells may then induce VSMC rounding up and separation via AGFs 
including Ang-2 (Robson et al., 2012; Pitman et al., 2013).  uNK cells also attract EVTs 
towards the SpAs via secretion of IL-8, CXCL10 and other cytokines (Hanna et al., 
2006; Lash et al., 2010b). EVT and uNK cells interact via EVT expression of HLA-C, 460 
potentially influencing their function (Xiong et al., 2013).  Both uNK cells and EVT may 
then induce dedifferentiation of VSMCs, through AGF secretion, particularly Ang-1 and 
Ang-2.  This synthetic phenotype increases their motility and VSMC migrate into the 
stroma surrounding remodelling SpAs where they undergo apoptosis and are 
phagocytosed by resident macrophages (Bulmer et al., 2012; Lash et al., 2016).  465 
Disruptions in any of these cell types and molecular mediators may contribute to failed 
SpA remodelling and hence to the pathogenesis of pregnancy complications. 
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Table I: Primary antibodies for immunohistochemistry 
 620 
1EDTA: pressure cook for 1 min in EDTA buffer pH 8  
2citrate: pressure cook for 1 min in citrate buffer pH 6  
3trypsin: incubate in 0.1% trypsin for 10 mins at 37°C 
  
Antibody Pre-
Treatment 
Dilution Incubation 
Time 
Species Company  Clone/ 
Cat# 
 
Tie-2 EDTA1  1:200 60 mins Goat R&D, Abingdon, UK 
 
AF313 
IFN-γR2 EDTA  1:100 60 mins Mouse Abcam, Cambridge, 
UK 
 
31606 
IFN-γR1 Nil 1:50 60 mins Rabbit Abcam 
 
61179 
VEGF-R1 Citrate2  1:200 60 mins Rabbit Insight Biotech, 
Wembley, UK 
 
9029 
VEGF-R2 Citrate 1:100 60 mins Mouse Insight Biotech 
 
6251 
VEGF-R3 Citrate 1:500 60 mins Rabbit Insight Biotech 
 
321 
TGF-βRI EDTA  1:50 60 mins Rabbit Abcam 
 
31013 
TGF-βRII Citrate 1:100 30 mins Rabbit Abcam 
 
28382 
H-caldesmon 
 
Citrate 1:100 60 mins Mouse Dako, Ely, UK M3557 
Calponin Trypsin3 1:80 30 mins Mouse Dako 
 
M3556 
Myosin 
Heavy Chain 
 
Citrate 1:600 60 mins Mouse Sigma-Aldrich, 
Poole, UK 
M7786 
α-smooth 
muscle actin 
 
Trypsin 1:75 30 mins Mouse Leica, Milton 
Keynes, UK 
SMA 
Smoothelin Citrate 1:100 60 mins Mouse Abcam 
 
8969 
Cleaved-
caspase 3 
Citrate 1:200 30 mins Mouse Cell Signalling, New 
England Biolabs, 
Hitchin, UK 
 
9661 
Ki67 Citrate 1:200 30 mins Mouse Leica 
 
MMI 
CD31 Citrate 1:20 60 mins Mouse Leica 
 
IAIO 
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Figure Legends 625 
Figure 1: Angiogenic growth factor receptors during spiral artery remodeling A) 
Representative photomicrographs of immunostaining for angiogenic growth receptors 
in non-remodelled (top 3 rows) and partially remodelled (bottom row) superficial 
myometrial spiral arteries in placental bed biopsies. The antibodies used are shown 
on the photomicrographs.  Immunoreactivity for vascular endothelial growth factor 630 
receptor 2 (VEGF-R2) and Tie-2 is increased in the wall of the partially remodelled 
artery compared with the non-remodelled artery. Scale bar 50µM.  B) Graphical 
representation of quickscore for receptor expression in non-remodelled and partially 
remodelled spiral arteries.  C) Non-transformed spiral arteries were laser capture 
microdissected from sections of placental bed biopsies stained with cresyl violet.  Real 635 
time RT-PCR was performed for GAPDH, H-caldesmon (Hcal), VEGF-R1, VEGF-R2, 
VEGF-R3, transforming growth factor beta receptors (TGFβ-R1, TGFβ-R2), interferon 
gamma receptors (IFNγ-R1, IFNγ-R2) and Tie-2.  As there is no comparator, data are 
shown as delta Ct relative to GAPDH.  Note that the lower the number the more 
abundant the mRNA.  Data are shown as mean±SEM.  640 
Figure 2: Loss of contractile phenotype during spiral artery remodelling A) 
Representative photomicrographs of immunostaining for cytokeratin 7 (demonstrating 
absence of trophoblast), α-SMA, H-Cal, MyHC, osteopontin and, calponin and 
smoothelin in vascular smooth muscle cells of non-remodelled and partially 
remodelled spiral arteries in placental bed biopsies.  Scale bar 50µM.  B) 645 
Quantification of α-SMA, H-Cal, MyHC, osteopontin and smoothelin in vascular 
smooth muscle cells of non-remodelled (n=15) and partially remodelled (n=15) spiral 
arteries normalised to calponin expression.  Statistical significance was determined by 
use of an unpaired t-Test.  
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650 
Figure 3: Vascular smooth muscle cell dedifferentiation by uterine natural killer cell 
derived growth factors A) Chorionic plate arteries (CPAs) were incubated with 
recombinant human growth factors (0, 1 or 10ng/ml) for 120 hours.  Transverse 
sections of each artery were stained with H-Cal and quantified for amount of 
expression using Adobe Photoshop.  Statistical significance was determined by use 655 
of an ANOVA with a Fisher’s post-hoc test, n=8 each group.  B) CPAs were incubated 
in uterine natural killer cell conditioned medium (uNK-CM) in the presence or absence 
of Ang-1 or Ang-2 neutralising antibodies (Ab; 1-2µg/ml) for 120 hours.  Transverse 
sections of each artery were stained with H-Cal and quantified for amount of 
expression using Adobe Photoshop.  Statistical significance was determined by use 660 
of an ANOVA with a Fisher’s post-hoc test, n=5 each group.  C) Immunostaining of 
CPAs for Tie-1 and Tie-2.  Note immunopositivity of VSMCs.  
Figure 4: Dedifferentiation of chorionic plate arteries (CPAs). CPAs were incubated 
with unconditioned medium (control; 20% (v/v)), uterine natural killer cell conditioned 665 
medium (uNK-CM), extravillous trophoblast (EVT)-CM or uNK/EVT-CM for 120 hours 
from either 8-10 or 12-14 weeks gestational age.  Transverse sections of each artery 
were stained with H-Cal (A), MyHC (B), α-SMA (C) or osteopontin (D) and quantified 
for amount of expression using Adobe Photoshop.  Statistical significance was 
determined by use of an ANOVA with a Fisher’s post-hoc test, n=6 each group.   670 
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